AUSTRALIAN LUNG CANCER CONFERENCE
5~7 April 2018

Program

 2018 ALCC PROGRAM

Conference theme: Improving patient care with technology 

Be sure to confirm your attendance for the sponsored symposiums in your registration. There are limited spots for these.

2018 Working Program_Website (24 KB)

Industry Sponsored Symposiums

Be sure to tick which symposiums you wish to attend in your registration. If you need to make an amendment to your registration please email ameliap@lungfoundation.com.au.

  • Pfizer evening symposium – Thursday 5 April
    Management of ALK-driven NSCLC patients with the aim of maximising their overall survival
  • AstraZeneca morning symposium – Friday 6 April
    Managing Acquired Resistance in EGFRm + NSCLC
  • Roche lunch symposium – Friday 6 April
    The evolving treatment paradigm in 1st line NSCL
    Speakers: Prof Tony Mok, Prof Ken O’Byrne, A/Prof Nick Pavlakis, Prof Ben Solomon
  • BMS evening symposium – Friday 6 April
    Immunotherapy: NOW and NEXT
    Speakers: Prof Thomas Lynch, Prof Michael Boyer, A/Prof Nick Pavlakis, Prof Ben Solomon
  • Slater + Gordon evening symposium – Friday 6 April
    Mesothelioma Treatment – The Current Landscape, Future Directions and Recent Study Results
    Speakers: A/Prof Matthew Conron
  • MSD morning symposium – Saturday 7 April
    Managing the Lung Cancer patient through the multi-disciplinary team pathway – a focus on best-practice in the new era of ImmunotherapyImmunotherapy is rapidly changing the management of metastatic lung cancer. New treatments bring the promise of improved outcomes for patients but added complexity for the MDT.Our faculty will discuss how best to integrate these new advances into daily treatment decisions whilst juggling rapidly evolving data and variability of treatment access across metropolitan and regional/ rural centres.

    This interactive discussion lead by a panel of experts will call on case study experiences from the clinic to address challenges and new options for patients.

  • Roche-Foundation Medicine lunch symposium – Saturday 7 April
    Comprehensive Genomic Profiling in Lung Cancer: On the pathway to
    precision oncology
    Speakers: Prof Tony Mok and Prof Stephen Clarke

Immunotherapy is rapidly changing the management of metastatic lung cancer. New treatments bring the promise of improved outcomes for patients but added complexity for the MDT. Our faculty will discuss how best to integrate these new advances into daily treatment decisions whilst juggling rapidly evolving data and variability of treatment access across metropolitan and regional/ rural centres. This interactive discussion lead by a panel of experts will call on case study experiences from the clinic to address challenges and new options for patients.

MSD sponsored symposium developed by an independent steering committee

  • Roche-Foundation Medicine morning symposium – Saturday 7 April

Empowering the patient voice forum

We invite all patients and carers to attend the half day consumer forum. It will include a panel discussion on media surrounding lung cancer. A Clinician, patient, and media reporter will be providing their perspectives with the focus on the insights in managing and dealing with the media and how the media portrays lung cancer. Below are the forum’s details.

When: Thursday 5 April 2018

Where: Hyatt Regency Sydney

When: 1pm – 5pm

Registration: Free of charge. Please call 1800 654 301 or email enquiries@lungfoundation.com.au  to RSVP.

We invite all attendees to stay for the conference welcome reception from 5pm – 6:30pm after the consumer forum.

Patient Workshop Flyer (181 KB)

Welcome Reception

Date:Thursday, 5 April 2018
Time:5.30pm - 6.30pm
Venue:Hyatt Regency, Sydney
Dress:Smart Casual
Cost:Delegate (Included)
Adult ($50.00)
Child 4-14yrs (Price on request)
Child less than 4yrs (Free)